Longitudinal Follow-Up of Serum and Urine Biomarkers Indicative of COVID-19-Associated Acute Kidney Injury: Diagnostic and Prognostic Impacts

被引:2
|
作者
Lablad, Yahya [1 ]
Vanhomwegen, Charlotte [1 ]
De Prez, Eric [1 ]
Antoine, Marie-Helene [1 ]
Hasan, Sania [1 ]
Baudoux, Thomas [1 ,2 ]
Nortier, Joelle [1 ]
机构
[1] Univ Libre Bruxelles, Fac Med, Lab Expt Nephrol, Erasme Campus,808 Route Lennik, B-1070 Brussels, Belgium
[2] Erasme Univ Hosp, Dept Nephrol Dialysis & Renal Transplantat, Erasme Campus, B-1070 Brussels, Belgium
关键词
AKI; COVID-19; biomarkers; NGAL; LAP; CCL14; cystatin C; suPAR; SOLUBLE UROKINASE RECEPTOR; COVID-19; PATIENTS;
D O I
10.3390/ijms242216495
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In patients hospitalized for severe COVID-19, the incidence of acute kidney injury (AKI) is approximately 40%. To predict and understand the implications of this complication, various blood and urine biomarkers have been proposed, including neutrophil gelatinase-associated lipocalin (NGAL), chemokine (C-C motif) ligand 14 (CCL14), cystatin C, leucine aminopeptidase (LAP), and soluble urokinase plasminogen activator (suPAR). This study, conducted between mid-January and early May 2021, aimed to assess the diagnostic and prognostic capabilities of these biomarkers in a cohort of COVID-19 patients monitored during the initial two weeks of hospitalization. Among the 116 patients included in this study, 48 developed AKI within the first three days of hospitalization (41%), with 29 requiring intensive care unit (ICU) admission, and the overall mortality rate was 18%. AKI patients exhibited a statistically significant increase in urinary LAP levels, indicating acute tubular injury as a potential mechanism underlying COVID-19-related renal damage. Conversely, urinary NGAL and CCL-14 excretion rates did not differ significantly between the AKI and non-AKI groups. Importantly, elevated plasma suPAR and cystatin C levels upon admission persisted throughout the first week of hospitalization and were associated with unfavorable outcomes, such as prolonged ICU stays and increased mortality, irrespective of AKI development. In conclusion, this study underscores the early predictive value of urinary LAP levels in identifying acute tubular injury in COVID-19-induced AKI. Moreover, elevated plasma suPAR and cystatin C levels serve as valuable prognostic markers, offering insights into the short-term morbidity and mortality risks among COVID-19 patients, regardless of AKI occurrence. These findings shed light on the complex interplay between COVID-19, renal injury, and biomarkers with diagnostic and prognostic potential.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Acute Peritoneal Dialysis With Percutaneous Catheter Insertion for COVID-19-Associated Acute Kidney Injury in Intensive Care: Experience From a UK Tertiary Center
    Bowes, Elaine
    Joslin, Jennifer
    Braide-Azikiwe, Dandisonba C. B.
    Tulley, Caroline
    Bramham, Kate
    Saha, Sujit
    Jayawardene, Satish
    Shakoane, Babakang
    Wilkins, C. Jason
    Hutchings, Sam
    Hopkins, Philip
    Lioudaki, Eirini
    Shaw, Catriona
    Cairns, Hugh
    Sharpe, Claire C.
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (02): : 265 - 271
  • [32] Self-identified Race and COVID-19-Associated Acute Kidney Injury and Inflammation: a Retrospective Cohort Study of Hospitalized Inner-City COVID-19 Patients
    Charoenngam, Nipith
    Ilori, Titilayo O.
    Holick, Michael F.
    Hochberg, Natasha S.
    Apovian, Caroline M.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (11) : 3487 - 3496
  • [33] Self-identified Race and COVID-19-Associated Acute Kidney Injury and Inflammation: a Retrospective Cohort Study of Hospitalized Inner-City COVID-19 Patients
    Nipith Charoenngam
    Titilayo O. Ilori
    Michael F. Holick
    Natasha S. Hochberg
    Caroline M. Apovian
    Journal of General Internal Medicine, 2021, 36 : 3487 - 3496
  • [34] Factors associated with mental health outcomes after COVID-19: A 24-month follow-up longitudinal study
    Guillen-Burgos, Hernan F.
    Galvez-Florez, Juan Francisco
    Moreno-Lopez, Sergio
    Gonzalez, Isabella
    Guillen, Manuela
    Anaya, Juan-Manuel
    GENERAL HOSPITAL PSYCHIATRY, 2023, 84 : 241 - 249
  • [35] Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: An international multi-centre observational cohort study
    Tan, Byorn W. L.
    Tan, Bryce W. Q.
    Tan, Amelia L. M.
    Schriver, Emily R.
    Gutierrez-Sacristan, Alba
    Das, Priyam
    Yuan, William
    Hutch, Meghan R.
    Garcia Barrio, Noelia
    Pedrera Jimenez, Miguel
    Abu-el-rub, Noor
    Morris, Michele
    Moal, Bertrand
    Verdy, Guillaume
    Cho, Kelly
    Ho, Yuk-Lam
    Patel, Lav P.
    Dagliati, Arianna
    Neuraz, Antoine
    Klann, Jeffrey G.
    South, Andrew M.
    Visweswaran, Shyam
    Hanauer, David A.
    Maidlow, Sarah E.
    Liu, Mei
    Mowery, Danielle L.
    Batugo, Ashley
    Makoudjou, Adeline
    Tippmann, Patric
    Zoeller, Daniela
    Brat, Gabriel A.
    Luo, Yuan
    Avillach, Paul
    Bellazzi, Riccardo
    Chiovato, Luca
    Malovini, Alberto
    Tibollo, Valentina
    Samayamuthu, Malarkodi Jebathilagam
    Balazote, Pablo Serrano
    Xia, Zongqi
    Loh, Ne Hooi Will
    Chiudinelli, Lorenzo
    Bonzel, Clara-Lea
    Hong, Chuan
    Zhang, Harrison G.
    Weber, Griffin M.
    Kohane, Isaac S.
    Cai, Tianxi
    Omenn, Gilbert S.
    Holmes, John H.
    ECLINICALMEDICINE, 2023, 55
  • [36] Neutrophil Gelatinase-Associated Lipocalin as a Follow-Up Marker in Critically Ill Pediatric Patients with Established Acute Kidney Injury
    Polat, Meltem
    Fidan, Kibriya
    Derinoz, Oksan
    Gonen, Sevim
    Soylemezoglu, Oguz
    RENAL FAILURE, 2013, 35 (03) : 352 - 356
  • [37] Presence of SARS-CoV-2 in urine is rare and not associated with acute kidney injury in critically ill COVID-19 patients
    Frithiof, Robert
    Bergqvist, Anders
    Jarhult, Josef D.
    Lipcsey, Miklos
    Hultstrom, Michael
    CRITICAL CARE, 2020, 24 (01)
  • [38] In silico evidence implicating novel mechanisms of Prunella vulgaris L. as a potential botanical drug against COVID-19-associated acute kidney injury
    Yang, Xue-Ling
    Wang, Chun-Xuan
    Wang, Jia-Xing
    Wu, Shi-Min
    Yong, Qing
    Li, Ke
    Yang, Ju-Rong
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [39] COVID-19-associated acute kidney injury patients treated with renal replacement therapy in the intensive care unit: A multicenter study in SAo Paulo, Brazil
    Samaan, Farid
    de Paula, Elisa Carneiro
    Guimaraes de Lima Souza, Fabrizzio Batista
    Cardoso Mendes, Luiz Fernando
    Gan Rossi, Paula Regina
    Penalva Freitas, Rafaela Andrade
    Nakagawa, Fernando Takahashi
    Maciel, Alexandre Toledo
    Aranha, Sylvia
    Osawa, Eduardo
    Konigsfeld, Henrique Pinheiro
    da Silva, Riberto Garcia
    Cintra de Souza, Ricardo Barbosa
    Coutinho, Saurus Mayer
    Vieira, Tales Dantas
    Thomaz, Karina De Bonis
    Silva Flato, Elias Marcos
    da Silva, Renata Cristina
    Andrade, Lucas Vicente
    Badaoui, Muna
    Badaoui, Eduardo Pogetti
    Goes, Miguel Angelo
    do Amaral, Sergio Henrique
    Cunha, Karlla
    Muniz, Ines Marin
    Sampaio, Jacqueline Siqueira
    Durao Junior, Marcelino de Souza
    Zanetta, Dirce M. Trevisan
    Burdmann, Emmanuel A.
    PLOS ONE, 2022, 17 (01):
  • [40] Presence of SARS-CoV-2 in urine is rare and not associated with acute kidney injury in critically ill COVID-19 patients
    Robert Frithiof
    Anders Bergqvist
    Josef D. Järhult
    Miklos Lipcsey
    Michael Hultström
    Critical Care, 24